Skip to main content

Table 3 Validation of Year 1 HPV Vaccination administrative vs community coverage survey

From: Implementation of a human papillomavirus vaccination demonstration project in Malawi: successes and challenges

  Facility-based coverage Community-based coverage  
Target (n) Coverage (%) 95% CI n Coverage (%) 95% CI p value
Zomba:
 1 dose 1930 91.2 89.9–92.5 309 87.7 83.3–92.1 0.05
 2 doses 1930 86.8 85.3–88.3 309 87.4 82.9–91.8 0.78
 3 doses 1930 84.7 83.1–86.3 309 85.8 81.3–90.3 0.63
Rumphi
 1 dose 4294 96.2 95.6–96.8 307 97.4 95.6–99.2 0.30
 2 doses 4294 93.2 92.4–94.0 307 95.8 93.9–97.8 0.09
 3 doses 4294 90.2 89.3–91.1 307 94.2a 91.7–96.7 0.03
Both districts
 1 dose 6224 94.6a 94.0–95.2 616 92.6 89.9–95.3 0.03
 2 doses 6224 91.2 90.5–91.5 616 91.6 89.0–94.2 0.77
 3 doses 6224 88.5 87.7–89.3 616 90.0 87.2–92.7 0.29
  1. CI confidence interval, % percentage, astatistically significant facility vs community based coverage